| Dr Fred Martin Weinblatt, MD | |
|
440 East Marshall Street, West Chester, PA 19380 | |
| (610) 696-8900 | |
| (610) 696-3890 |
| Full Name | Dr Fred Martin Weinblatt |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 48 Years |
| Location | 440 East Marshall Street, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194802165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | MD021550E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Chester County Hospital | West chester, PA | Hospital |
| University Medical Center Of Princeton At Plainsboro | Plainsboro, NJ | Hospital |
| Pennsylvania Hospital | Philadelphia, PA | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Care Associates Of The University Of Pennsylvania Health | 4688588866 | 517 |
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
Researchers have identified a microRNA liver gene, miR-27b, which regulates lipid (cholesterol or fat) levels in the blood. This regulator gene controls multiple genes involved in dyslipidemia—abnormal blood cholesterol levels that can contribute to heart disease.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
The accurate measurement of blood pressure is essential for the diagnosis and management of hypertension, a major risk factor for heart disease and stroke, according to an updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
› Verified 8 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
Researchers have identified a microRNA liver gene, miR-27b, which regulates lipid (cholesterol or fat) levels in the blood. This regulator gene controls multiple genes involved in dyslipidemia—abnormal blood cholesterol levels that can contribute to heart disease.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
The accurate measurement of blood pressure is essential for the diagnosis and management of hypertension, a major risk factor for heart disease and stroke, according to an updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
› Verified 8 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
Researchers have identified a microRNA liver gene, miR-27b, which regulates lipid (cholesterol or fat) levels in the blood. This regulator gene controls multiple genes involved in dyslipidemia—abnormal blood cholesterol levels that can contribute to heart disease.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
The accurate measurement of blood pressure is essential for the diagnosis and management of hypertension, a major risk factor for heart disease and stroke, according to an updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fred Martin Weinblatt, MD 440 East Marshall Street, West Chester, PA 19380 Ph: (610) 696-8900 | Dr Fred Martin Weinblatt, MD 440 East Marshall Street, West Chester, PA 19380 Ph: (610) 696-8900 |
News Archive
Researchers have identified a microRNA liver gene, miR-27b, which regulates lipid (cholesterol or fat) levels in the blood. This regulator gene controls multiple genes involved in dyslipidemia—abnormal blood cholesterol levels that can contribute to heart disease.
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
The accurate measurement of blood pressure is essential for the diagnosis and management of hypertension, a major risk factor for heart disease and stroke, according to an updated American Heart Association scientific statement on blood pressure measurement in humans, published in the American Heart Association journal Hypertension.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
› Verified 8 days ago
Dr. Marjorie Saul, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1246 W Chester Pike, Suite 308, West Chester, PA 19382 Phone: 610-696-5771 Fax: 610-696-5922 | |
Burton T Mark, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 440 E. Marshall St, West Chester, PA 19380 Phone: 610-696-8900 Fax: 610-344-7760 | |
Dr. Samira Dabiri Zanjani, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 210 Willowbrook Ln, West Chester, PA 19382 Phone: 610-696-8900 Fax: 610-696-3890 | |
Dr. Carol Ann Persons, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 520 Raspberry Ln, West Chester, PA 19382 Phone: 610-918-1946 | |
Dr. Peter David Schindler, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 748 Denton Hollow Rd, West Chester, PA 19382 Phone: 610-793-6740 Fax: 610-793-9237 | |
Terrence Boyadjis, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 790 E Market St, Suite 245, West Chester, PA 19382 Phone: 610-738-9576 |